Offer - Urjas Oil for just ₹ 1 X
Rasipar 1 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Parkinson's Disease.
The correct dosage of Rasipar 1 Mg Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
While these are the most often observed Rasipar 1 Mg Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Rasipar 1 Mg Tablet are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Rasipar 1 Mg Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. Further, the section on Rasipar 1 Mg Tablet related warnings talks about Rasipar 1 Mg Tablet's effects on the liver, heart and kidney.
Rasipar 1 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Psychosis, Low Blood Pressure (Hypotension) are examples of such conditions. Other contraindications of Rasipar 1 Mg Tablet have been discussed in the sections ahead.
Drug reaction of Rasipar 1 Mg Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Rasipar 1 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Rasipar 1 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Rasipar 1 Mg Tablet safe for pregnant women?
Rasipar can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Rasipar right away. Take your doctor's advice before taking it again.
Is the use of Rasipar 1 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Rasipar. So it is adviced to consult the doctor before using it.
What is the effect of Rasipar 1 Mg Tablet on the Kidneys?
Rasipar has very mild side effects on the kidneys.
What is the effect of Rasipar 1 Mg Tablet on the Liver?
Rasipar has very mild side effects on the liver.
What is the effect of Rasipar 1 Mg Tablet on the Heart?
There are no any side effects of Rasipar for the heart.
If you are suffering from any of the following diseases, you should not take Rasipar 1 Mg Tablet unless your doctor advises you to do so -
Is this Rasipar 1 Mg Tablet habit forming or addictive?
No, there is no any evidence that Rasipar 1 Mg Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Rasipar 1 Mg Tablet, you should not drive or work on any heavy machine, as Rasipar 1 Mg Tablet can make you drowsy.
Is it safe?
Rasipar 1 Mg Tablet is safe as it does not bear any side effects.
Is it able to treat mental disorders?
Rasipar 1 Mg Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Rasipar 1 Mg Tablet
Eating certain foods may increase the time it takes Rasipar 1 Mg Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Rasipar 1 Mg Tablet
Taking alcohol with Rasipar 1 Mg Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Azilect (rasagiline mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 432
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1085-1086